Trials / Completed
CompletedNCT05285085
Real World Evidence Study of Statin Use in Brazil
Real World Evidence Study for Assessing Statin Use for Primary and Secondary Prevention of Cardiovascular Disease in Primary Care in Brazil
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,133,900 (actual)
- Sponsor
- Hospital Israelita Albert Einstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A cross-sectional real-world data study designed to assess the use of statins in individuals assisted within the primary care system in Brazil.
Detailed description
Considering the high cardiovascular risk associated to high cholesterol levels, assessing the use of statins in secondary prevention as well as primary prevention individuals in real world settings is key to enable public health policy improvements. The aim of the present study is to assess statins use in primary and secondary prevention individuals assisted by community care workers in the primary care system in Brazil, using a free real world data collection tool (epHealth database). Evaluating factors associated with statins use as well as high dose statins use are also objectives of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Statin | Statin use |
Timeline
- Start date
- 2021-11-19
- Primary completion
- 2021-12-15
- Completion
- 2021-12-15
- First posted
- 2022-03-17
- Last updated
- 2024-05-14
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05285085. Inclusion in this directory is not an endorsement.